GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Caspase Dronc (EC 3.4.22.-) (NEDD2-like caspase) [Cleaved into: Caspase Nc subunit 1; Caspase Nc subunit 2]

 DRONC_DROME             Reviewed;         450 AA.
Q9XYF4;
23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
01-NOV-1999, sequence version 1.
03-JUL-2019, entry version 171.
RecName: Full=Caspase Dronc;
EC=3.4.22.-;
AltName: Full=NEDD2-like caspase;
Contains:
RecName: Full=Caspase Nc subunit 1;
Contains:
RecName: Full=Caspase Nc subunit 2;
Flags: Precursor;
Name=Dronc {ECO:0000312|FlyBase:FBgn0026404};
Synonyms=Nc {ECO:0000312|EMBL:AAF50180.1};
ORFNames=CG8091 {ECO:0000312|FlyBase:FBgn0026404};
Drosophila melanogaster (Fruit fly).
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
Ephydroidea; Drosophilidae; Drosophila; Sophophora.
NCBI_TaxID=7227;
[1] {ECO:0000305, ECO:0000312|EMBL:AAD26625.1}
NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY,
DEVELOPMENTAL STAGE, AND INDUCTION.
TISSUE=Embryo {ECO:0000269|PubMed:10200258};
PubMed=10200258; DOI=10.1073/pnas.96.8.4307;
Dorstyn L., Colussi P.A., Quinn L.M., Richardson H., Kumar S.;
"DRONC, an ecdysone-inducible Drosophila caspase.";
Proc. Natl. Acad. Sci. U.S.A. 96:4307-4312(1999).
[2] {ECO:0000305, ECO:0000312|EMBL:CAB53565.1}
NUCLEOTIDE SEQUENCE, FUNCTION, AND INTERACTION WITH DRICE AND DIAP1.
TISSUE=Embryo {ECO:0000269|PubMed:10675329};
PubMed=10675329; DOI=10.1093/emboj/19.4.598;
Meier P., Silke J., Leevers S.J., Evan G.I.;
"The Drosophila caspase DRONC is regulated by DIAP1.";
EMBO J. 19:598-611(2000).
[3] {ECO:0000312|EMBL:AAF50180.1}
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
PubMed=10731132; DOI=10.1126/science.287.5461.2185;
Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
"The genome sequence of Drosophila melanogaster.";
Science 287:2185-2195(2000).
[4] {ECO:0000305, ECO:0000312|EMBL:AAF50180.1}
GENOME REANNOTATION.
STRAIN=Berkeley;
PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
Lewis S.E.;
"Annotation of the Drosophila melanogaster euchromatic genome: a
systematic review.";
Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
[5] {ECO:0000312|EMBL:AAL13976.1}
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=Berkeley {ECO:0000269|PubMed:12537569};
TISSUE=Larva {ECO:0000269|PubMed:12537569}, and
Pupae {ECO:0000269|PubMed:12537569};
PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
Rubin G.M., Celniker S.E.;
"A Drosophila full-length cDNA resource.";
Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
[6]
FUNCTION.
PubMed=10984473; DOI=10.1074/jbc.M002935200;
Quinn L.M., Dorstyn L., Mills K., Colussi P.A., Chen P., Coombe M.,
Abrams J., Kumar S., Richardson H.;
"An essential role for the caspase dronc in developmentally programmed
cell death in Drosophila.";
J. Biol. Chem. 275:40416-40424(2000).
[7]
UBIQUITINATION AND SUBSEQUENT DEGRADATION.
PubMed=12021771; DOI=10.1038/ncb799;
Wilson R., Goyal L., Ditzel M., Zachariou A., Baker D.A., Agapite J.,
Steller H., Meier P.;
"The DIAP1 RING finger mediates ubiquitination of Dronc and is
indispensable for regulating apoptosis.";
Nat. Cell Biol. 4:445-450(2002).
[8] {ECO:0000305}
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 114-125 IN COMPLEX WITH
DIAP1, FUNCTION, AND MUTAGENESIS OF PHE-118.
PubMed=14517550; DOI=10.1038/nsb989;
Chai J., Yan N., Huh J.R., Wu J.-W., Li W., Hay B.A., Shi Y.;
"Molecular mechanism of Reaper-Grim-Hid-mediated suppression of DIAP1-
dependent Dronc ubiquitination.";
Nat. Struct. Biol. 10:892-898(2003).
-!- FUNCTION: Involved in the activation cascade of caspases
responsible for apoptosis execution. Effector of steroid-mediated
apoptosis during insect metamorphosis. Overexpression promotes
programmed cell death. Interaction with Diap1 is required to
suppress Dronc-mediated cell death; via Diap1-mediated
ubiquitination of Dronc. Rate-limiting caspase in rpr and hid
death pathway. {ECO:0000269|PubMed:10200258,
ECO:0000269|PubMed:10675329, ECO:0000269|PubMed:10984473,
ECO:0000269|PubMed:14517550}.
-!- SUBUNIT: Interacts with Diap1; residues 114-125 interact with the
second BIR domain of Diap1. Can form a stable complex with Drice.
Rpr can out-compete Dronc for binding Diap1, therefore removing
Diap1-mediated ubiquitination. {ECO:0000269|PubMed:10675329,
ECO:0000269|PubMed:14517550}.
-!- INTERACTION:
Q7KLI1:Dark; NbExp=3; IntAct=EBI-108311, EBI-3404349;
Q24306:Diap1; NbExp=9; IntAct=EBI-108311, EBI-456419;
O01382:Drice; NbExp=3; IntAct=EBI-108311, EBI-91422;
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
-!- TISSUE SPECIFICITY: Ubiquitously expressed in embryos during early
stages of development. In late third instar larvae, dramatic up-
regulation in salivary glands and midgut before histolysis of
these tissues. {ECO:0000269|PubMed:10200258}.
-!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
{ECO:0000269|PubMed:10200258}.
-!- INDUCTION: By ecdysone; exposure of salivary glands and midgut
isolated from second instar larvae results in a massive increase
in levels. {ECO:0000269|PubMed:10200258}.
-!- PTM: Ubiquitinated by Diap1, leading to its subsequent
degradation. {ECO:0000269|PubMed:12021771}.
-!- MISCELLANEOUS: The promiscuous caspase inhibitor p35 is neither
cleaved by Dronc in vitro nor blocks Dronc activity in vivo.
{ECO:0000269|PubMed:10675329}.
-!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF104357; AAD26625.1; -; mRNA.
EMBL; AJ242796; CAB53565.1; -; mRNA.
EMBL; AE014296; AAF50180.1; -; Genomic_DNA.
EMBL; AY058747; AAL13976.1; -; mRNA.
RefSeq; NP_524017.1; NM_079293.4.
PDB; 1Q4Q; X-ray; 2.10 A; K/L/M/N/O/P/Q/R/S/T=114-125.
PDB; 2FP3; X-ray; 2.50 A; A=136-450.
PDB; 3J9K; EM; 4.10 A; B/D/F/H/J/L/N/P/R/T/V/X/Z/b/d/f=1-450.
PDBsum; 1Q4Q; -.
PDBsum; 2FP3; -.
PDBsum; 3J9K; -.
SMR; Q9XYF4; -.
BioGrid; 64560; 67.
DIP; DIP-31484N; -.
IntAct; Q9XYF4; 4.
MINT; Q9XYF4; -.
STRING; 7227.FBpp0076076; -.
MEROPS; C14.019; -.
iPTMnet; Q9XYF4; -.
PaxDb; Q9XYF4; -.
PRIDE; Q9XYF4; -.
EnsemblMetazoa; FBtr0076347; FBpp0076076; FBgn0026404.
GeneID; 39173; -.
KEGG; dme:Dmel_CG8091; -.
CTD; 39173; -.
FlyBase; FBgn0026404; Dronc.
eggNOG; KOG3573; Eukaryota.
eggNOG; ENOG410ZQIE; LUCA.
GeneTree; ENSGT00940000174288; -.
InParanoid; Q9XYF4; -.
KO; K20009; -.
OMA; VMVLMTH; -.
OrthoDB; 1092723at2759; -.
PhylomeDB; Q9XYF4; -.
EvolutionaryTrace; Q9XYF4; -.
GenomeRNAi; 39173; -.
PRO; PR:Q9XYF4; -.
Proteomes; UP000000803; Chromosome 3L.
Bgee; FBgn0026404; Expressed in 35 organ(s), highest expression level in adult organism.
Genevisible; Q9XYF4; DM.
GO; GO:0043293; C:apoptosome; IDA:FlyBase.
GO; GO:0005737; C:cytoplasm; IDA:FlyBase.
GO; GO:0050700; F:CARD domain binding; ISM:FlyBase.
GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:FlyBase.
GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IBA:GO_Central.
GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IDA:FlyBase.
GO; GO:0004175; F:endopeptidase activity; IDA:FlyBase.
GO; GO:0042803; F:protein homodimerization activity; IDA:FlyBase.
GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:FlyBase.
GO; GO:0006915; P:apoptotic process; IMP:FlyBase.
GO; GO:0007417; P:central nervous system development; IMP:FlyBase.
GO; GO:0022416; P:chaeta development; IMP:FlyBase.
GO; GO:0048749; P:compound eye development; IMP:FlyBase.
GO; GO:0048813; P:dendrite morphogenesis; IMP:FlyBase.
GO; GO:0008340; P:determination of adult lifespan; IMP:FlyBase.
GO; GO:0035234; P:ectopic germ cell programmed cell death; IMP:FlyBase.
GO; GO:0001700; P:embryonic development via the syncytial blastoderm; TAS:FlyBase.
GO; GO:0097194; P:execution phase of apoptosis; IBA:GO_Central.
GO; GO:0008258; P:head involution; IMP:FlyBase.
GO; GO:0007516; P:hemocyte development; IMP:FlyBase.
GO; GO:0035006; P:melanization defense response; IMP:FlyBase.
GO; GO:0007552; P:metamorphosis; TAS:FlyBase.
GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:FlyBase.
GO; GO:0016322; P:neuron remodeling; IMP:FlyBase.
GO; GO:0045476; P:nurse cell apoptotic process; IGI:FlyBase.
GO; GO:0046672; P:positive regulation of compound eye retinal cell programmed cell death; IMP:FlyBase.
GO; GO:2001269; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IDA:FlyBase.
GO; GO:0010940; P:positive regulation of necrotic cell death; IMP:FlyBase.
GO; GO:0012501; P:programmed cell death; IDA:FlyBase.
GO; GO:0010623; P:programmed cell death involved in cell development; IMP:FlyBase.
GO; GO:0016540; P:protein autoprocessing; IDA:FlyBase.
GO; GO:0051291; P:protein heterooligomerization; IDA:FlyBase.
GO; GO:0010506; P:regulation of autophagy; IGI:FlyBase.
GO; GO:0010941; P:regulation of cell death; IMP:FlyBase.
GO; GO:0046668; P:regulation of retinal cell programmed cell death; NAS:FlyBase.
GO; GO:0035070; P:salivary gland histolysis; IMP:FlyBase.
GO; GO:0007291; P:sperm individualization; IMP:FlyBase.
GO; GO:0031638; P:zymogen activation; IDA:FlyBase.
CDD; cd00032; CASc; 1.
InterPro; IPR029030; Caspase-like_dom_sf.
InterPro; IPR033139; Caspase_cys_AS.
InterPro; IPR011029; DEATH-like_dom_sf.
InterPro; IPR002398; Pept_C14.
InterPro; IPR002138; Pept_C14_p10.
InterPro; IPR001309; Pept_C14_p20.
InterPro; IPR015917; Pept_C14A.
PANTHER; PTHR10454; PTHR10454; 1.
PRINTS; PR00376; IL1BCENZYME.
SMART; SM00115; CASc; 1.
SUPFAM; SSF47986; SSF47986; 1.
SUPFAM; SSF52129; SSF52129; 1.
PROSITE; PS01122; CASPASE_CYS; 1.
PROSITE; PS50207; CASPASE_P10; 1.
PROSITE; PS50208; CASPASE_P20; 1.
1: Evidence at protein level;
3D-structure; Apoptosis; Complete proteome; Cytoplasm; Hydrolase;
Protease; Reference proteome; Thiol protease; Ubl conjugation;
Zymogen.
PROPEP 1 134 {ECO:0000303|PubMed:10200258}.
/FTId=PRO_0000004670.
CHAIN 135 320 Caspase Nc subunit 1.
/FTId=PRO_0000004671.
PROPEP 321 324 {ECO:0000303|PubMed:10200258}.
/FTId=PRO_0000004672.
CHAIN 325 450 Caspase Nc subunit 2.
/FTId=PRO_0000004673.
DOMAIN 64 109 CARD. {ECO:0000255}.
REGION 114 125 Required for binding th.
ACT_SITE 271 271 {ECO:0000250|UniProtKB:P29466}.
ACT_SITE 318 318 {ECO:0000250|UniProtKB:P29466}.
MUTAGEN 118 118 F->E: Disrupts interaction with Diap1.
{ECO:0000269|PubMed:14517550}.
STRAND 195 202 {ECO:0000244|PDB:2FP3}.
HELIX 216 229 {ECO:0000244|PDB:2FP3}.
STRAND 232 237 {ECO:0000244|PDB:2FP3}.
HELIX 242 253 {ECO:0000244|PDB:2FP3}.
HELIX 256 260 {ECO:0000244|PDB:2FP3}.
STRAND 264 270 {ECO:0000244|PDB:2FP3}.
STRAND 280 282 {ECO:0000244|PDB:2FP3}.
STRAND 288 290 {ECO:0000244|PDB:2FP3}.
HELIX 291 296 {ECO:0000244|PDB:2FP3}.
TURN 300 302 {ECO:0000244|PDB:2FP3}.
HELIX 304 306 {ECO:0000244|PDB:2FP3}.
STRAND 311 316 {ECO:0000244|PDB:2FP3}.
STRAND 366 371 {ECO:0000244|PDB:2FP3}.
TURN 380 382 {ECO:0000244|PDB:2FP3}.
HELIX 385 400 {ECO:0000244|PDB:2FP3}.
TURN 401 403 {ECO:0000244|PDB:2FP3}.
HELIX 406 418 {ECO:0000244|PDB:2FP3}.
STRAND 419 423 {ECO:0000244|PDB:2FP3}.
STRAND 425 427 {ECO:0000244|PDB:2FP3}.
STRAND 431 436 {ECO:0000244|PDB:2FP3}.
SEQUENCE 450 AA; 51141 MW; 640A9725202A7E65 CRC64;
MQPPELEIGM PKRHREHIRK NLNILVEWTN YERLAMECVQ QGILTVQMLR NTQDLNGKPF
NMDEKDVRVE QHRRLLLKIT QRGPTAYNLL INALRNINCL DAAVLLESVD ESDSRPPFIS
LNERRTSRKS ADIVDTPSPE ASEGPCVSKL RNEPLGALTP YVGVVDGPEV KKSKKIHGGD
SAILGTYKMQ SRFNRGVLLM VNIMDYPDQN RRRIGAEKDS KSLIHLFQEL NFTIFPYGNV
NQDQFFKLLT MVTSSSYVQN TECFVMVLMT HGNSVEGKEK VEFCDGSVVD MQKIKDHFQT
AKCPYLVNKP KVLMFPFCRG DEYDLGHPKN QGNLMEPVYT AQEEKWPDTQ TEGIPSPSTN
VPSLADTLVC YANTPGYVTH RDLDTGSWYI QKFCQVMADH AHDTDLEDIL KKTSEAVGNK
RTKKGSMQTG AYDNLGFNKK LYFNPGFFNE


Related products :

Catalog number Product name Quantity
U1058h CLIA CAD,CAD,Caspase-activated deoxyribonuclease,Caspase-activated DNase,Caspase-activated nuclease,CPAN,DFF2,DFF40,DFF-40,DFFB,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit 96T
18-661-15034 DNA fragmentation factor subunit beta - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD; Caspase-activated nuclease; CPAN 0.1 mg
18-661-15031 DNA fragmentation factor subunit beta - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD; Caspase-activated nuclease; CPAN 0.1 mg
18-661-15032 DNA fragmentation factor subunit beta - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD; Caspase-activated nuclease; CPAN 0.1 mg
18-661-15033 DNA fragmentation factor subunit beta - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD; Caspase-activated nuclease; CPAN 0.1 mg
18-661-15054 DNA fragmentation factor subunit beta - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD; Caspase-activated nuclease; CPAN 0.1 mg
18-661-15069 DNA fragmentation factor subunit beta - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD; Caspase-activated nuclease; CPAN 0.1 mg
bs-0087P Peptides: active Caspase 3(caspase-3 p12 subunit) Protein Length:12-25 amino acids. 200ug lyophilized
E1058h ELISA CAD,CAD,Caspase-activated deoxyribonuclease,Caspase-activated DNase,Caspase-activated nuclease,CPAN,DFF2,DFF40,DFF-40,DFFB,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subuni 96T
E1058h ELISA kit CAD,CAD,Caspase-activated deoxyribonuclease,Caspase-activated DNase,Caspase-activated nuclease,CPAN,DFF2,DFF40,DFF-40,DFFB,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor s 96T
20-272-190961 Caspase 2 - Mouse monoclonal [18E809] to Caspase 2; EC 3.4.22.55; CASP-2; ICH-1 protease; NEDD2 protein; Neural precursor cell expressed developmentally down-regulated protein 2; NEDD-2 Monoclonal 0.2 ml
20-272-191595 Caspase 2 - Mouse monoclonal [4i13] to Caspase 2; EC 3.4.22.55; CASP-2; ICH-1 protease; NEDD2 protein; Neural precursor cell expressed developmentally down-regulated protein 2; NEDD-2 Monoclonal 0.05 ml
20-272-191628 Caspase 2 - Mouse monoclonal [3G63] to Caspase 2; EC 3.4.22.55; CASP-2; ICH-1 protease; NEDD2 protein; Neural precursor cell expressed developmentally down-regulated protein 2; NEDD-2 Monoclonal 0.1 mg
18-783-76408 RABBIT ANTI MOUSE CAD (aa314-329) - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD Polyclonal 0.1 mg
18-783-76333 RABBIT ANTI MOUSE CAD (aa205-222) - EC 3.-.-.-; DNA fragmentation factor 40 kDa subunit; DFF-40; Caspase-activated deoxyribonuclease; Caspase-activated DNase; CAD Polyclonal 0.1 mg
E1058r ELISA CAD,Cad,Caspase-activated deoxyribonuclease,Caspase-activated DNase,DFF-40,Dffb,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit beta,Rat,Rattus norvegicus 96T
E1058m ELISA CAD,Cad,Caspase-activated deoxyribonuclease,Caspase-activated DNase,DFF-40,Dffb,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit beta,Mouse,Mus musculus 96T
U1058r CLIA CAD,Cad,Caspase-activated deoxyribonuclease,Caspase-activated DNase,DFF-40,Dffb,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit beta,Rat,Rattus norvegicus 96T
E1058m ELISA kit CAD,Cad,Caspase-activated deoxyribonuclease,Caspase-activated DNase,DFF-40,Dffb,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit beta,Mouse,Mus musculus 96T
E1058r ELISA kit CAD,Cad,Caspase-activated deoxyribonuclease,Caspase-activated DNase,DFF-40,Dffb,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit beta,Rat,Rattus norvegicus 96T
U1058m CLIA CAD,Cad,Caspase-activated deoxyribonuclease,Caspase-activated DNase,DFF-40,Dffb,DNA fragmentation factor 40 kDa subunit,DNA fragmentation factor subunit beta,Mouse,Mus musculus 96T
EIAAB06987 CASH,CASH,CASP8 and FADD-like apoptosis regulator,CASP8AP1,Caspase homolog,Caspase-eight-related protein,Caspase-like apoptosis regulatory protein,Casper,Cellular FLICE-like inhibitory protein,CFLAR,c
EIAAB06986 CASH,Cash,CASP8 and FADD-like apoptosis regulator,Caspase homolog,Caspase-eight-related protein,Caspase-like apoptosis regulatory protein,Casper,Cellular FLICE-like inhibitory protein,Cflar,c-FLIP,CLA
bs-6858R-Cy3 Rabbit Anti-Caspase 4+Caspase 11 Polyclonal Antibody, Cy3 Conjugated 100ul
bs-6858R-Cy7 Rabbit Anti-Caspase 4+Caspase 11 Polyclonal Antibody, Cy7 Conjugated 100ul
Pathways :
WP2359: Parkin-Ubiquitin Proteasomal System pathway
WP88: Toll Like Receptor signaling
WP1965: VEGF-receptor Signal Transduction
WP1614: 1- and 2-Methylnaphthalene degradation
WP1644: DNA replication
WP1671: Methane metabolism
WP1693: Purine metabolism
WP1718: Vitamin B6 metabolism
WP2292: Chemokine signaling pathway
WP1566: Citrate cycle (TCA cycle)
WP1634: Butanoate metabolism
WP1663: Homologous recombination
WP1680: Oxidative phosphorylation
WP1711: Trinitrotoluene degradation
WP2272: Pathogenic Escherichia coli infection
WP1626: Benzoate degradation via CoA ligation
WP1655: Geraniol degradation
WP1672: Mismatch repair
WP1694: Pyrimidine metabolism

Related Genes :
[Casp2 Ich1 Nedd-2 Nedd2] Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]
[CASP2 ICH1 NEDD2] Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]
[Dredd DCP2 CG7486] Caspase-8 (EC 3.4.22.61) (Death-related ced-3/NEDD2-like protein) [Cleaved into: Caspase-8 subunit p15; Caspase-8 subunit p10]
[Drice ICE CG7788] Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]
[Casp4 Casp11 Caspl Ich3] Caspase-4 (CASP-4) (EC 3.4.22.64) (Caspase-11) (CASP-11) (Protease ICH-3) [Cleaved into: Caspase-4 subunit p10; Caspase-4 subunit p20]
[Casp7 Lice2 Mch3] Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]
[Casp3 Cpp32] Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]
[Casp2 Ich1] Caspase-2 (CASP-2) (EC 3.4.22.55) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]
[CASP4 ICH2] Caspase-4 (CASP-4) (EC 3.4.22.57) (ICE and Ced-3 homolog 2) (ICH-2) (ICE(rel)-II) (Mih1) (Protease TX) [Cleaved into: Caspase-4 subunit 1; Caspase-4 subunit 2]
[CASP10 MCH4] Caspase-10 (CASP-10) (EC 3.4.22.63) (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2) (FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12]
[Casp6] Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11]
[csp-1 Y48E1B.13] Caspase A (EC 3.4.22.36) [Cleaved into: Caspase A subunit p16; Caspase A subunit p14]
[CASP3 CPP32] Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]
[Casp3 Cpp32] Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]
[CASP8 MCH5] Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]
[CASP7 MCH3] Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]
[CASP6 MCH2] Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11]
[CASP14] Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]
[Casp6 Mch2] Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11]
[ced-3 C48D1.2] Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]
[CASP3] Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]
[CASP3] Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]
[csp-2 Y73B6BL.7] Putative inactive caspase B [Cleaved into: Putative inactive caspase B subunit p31; Putative inactive caspase B subunit p17; Putative inactive caspase subunit p14]
[CFLAR CASH CASP8AP1 CLARP MRIT] CASP8 and FADD-like apoptosis regulator (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12]
[Cflar Cash] CASP8 and FADD-like apoptosis regulator (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12]
[CASP4] Caspase-4 (CASP-4) (EC 3.4.22.57) [Cleaved into: Caspase-4 subunit 1; Caspase-4 subunit 2]
[NLRP1 CARD7 DEFCAP KIAA0926 NAC NALP1] NACHT, LRR and PYD domains-containing protein 1 (Caspase recruitment domain-containing protein 7) (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain)
[Espl1 Esp1 Kiaa0165] Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)
[CARD16 COP COP1] Caspase recruitment domain-containing protein 16 (Caspase recruitment domain-only protein 1) (CARD-only protein 1) (Caspase-1 inhibitor COP) (Pseudo interleukin-1 beta converting enzyme) (Pseudo-ICE) (Pseudo-IL1B-converting enzyme)
[CASP3] Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]

Bibliography :